What is the appropriate ketamine infusion preparation and rate for a 100‑kg intubated, agitated, hypotensive adult using one 100 mg vial mixed in 100 ml saline?

Ketamine Infusion for Sedation in a Hypotensive, Agitated, Intubated Adult

For a 100‑kg intubated, agitated, hypotensive adult, mix 100 mg ketamine in 100 mL saline (1 mg/mL concentration) and infuse at 10–25 mL/hour (0.1–0.25 mg/kg/hour), starting at the lower rate and titrating every 15–30 minutes based on sedation depth and hemodynamic response. 1

Preparation of the Infusion

• Mix 100 mg ketamine (one vial) in 100 mL normal saline to yield a final concentration of 1 mg/mL. 1
• This dilution is consistent with FDA‑approved maintenance infusion protocols, which recommend 1 mg/mL for continuous administration. 1
• Inspect the solution visually for particulate matter or discoloration before administration; discard if either is present. 1

Initial Infusion Rate

• Begin at 10 mL/hour (10 mg/hour or 0.1 mg/kg/hour for a 100‑kg patient). 1
• The FDA label specifies a maintenance infusion range of 0.1–0.5 mg/minute (6–30 mg/hour) for general anesthesia, which translates to 0.06–0.3 mg/kg/hour in a 100‑kg patient. 1
• For sedation of an agitated, intubated patient, start at the lower end of this range to minimize the risk of hypotension, particularly in a patient who is already hypotensive. 2, 3

Titration Protocol

• Increase the infusion rate by 5–10 mL/hour (5–10 mg/hour) every 15–30 minutes until adequate sedation is achieved, defined as cessation of agitation, tolerance of the endotracheal tube, and synchrony with the ventilator. 1
• The maximum infusion rate should not exceed 25 mL/hour (25 mg/hour or 0.25 mg/kg/hour) in a hypotensive patient, as higher doses are associated with significantly increased odds of hypotension (OR 7.0,95% CI 3.0–16.6), bradycardia (OR 7.5,95% CI 1.5–36.6), and oxygen desaturation (OR 6.0,95% CI 1.8–19.9). 3
• If sedation remains inadequate at 25 mL/hour, consider adding a benzodiazepine (e.g., midazolam 1–2 mg IV bolus, then 1–5 mg/hour infusion) rather than escalating ketamine further. 1, 4

Hemodynamic Monitoring and Management

• Continuously monitor blood pressure, heart rate, and oxygen saturation during ketamine infusion, as hypotension is the most common adverse effect in patients with elevated shock index (pulse rate ÷ systolic blood pressure ≥0.9). 2
• In a 100‑kg hypotensive patient, the shock index is likely elevated, predicting a blunted hypertensive response to ketamine and a 26% risk of hypotension (95% CI 12–45%), compared with only 2% in normotensive patients. 2
• If systolic blood pressure falls below 90 mmHg or mean arterial pressure drops below 65 mmHg, reduce the ketamine infusion rate by 50% and initiate or escalate vasopressor support with norepinephrine. 5, 6
• Administer a minimum 30 mL/kg crystalloid bolus (3 L for a 100‑kg patient) before or concurrent with ketamine infusion to optimize preload and mitigate vasodilatory effects. 5

Vasopressor Support in Hypotensive Patients

• If the patient remains hypotensive despite fluid resuscitation, start norepinephrine at 0.1 mcg/kg/min (10 mcg/min for a 100‑kg patient) via central venous access, targeting a mean arterial pressure of 65 mmHg. 5, 6
• Prepare norepinephrine by adding 4 mg to 250 mL D5W (16 mcg/mL) or, if using the same 100 mL saline bag approach, add 1 mg norepinephrine to 100 mL saline (10 mcg/mL) and infuse at 60 mL/hour to deliver 10 mcg/min. 5
• Peripheral IV administration of norepinephrine is acceptable as a temporary bridge if central access is unavailable, but transition to central access as soon as practical to minimize extravasation risk. 5
• If extravasation occurs, immediately infiltrate phentolamine 5–10 mg diluted in 10–15 mL saline at the site to prevent tissue necrosis. 5, 6

Respiratory Monitoring

• Ensure the patient is mechanically ventilated before starting ketamine infusion, as rapid administration or high doses can cause respiratory depression. 1
• Monitor for laryngospasm (1.3% incidence, 95% CI 0.3–2.3%), which is more common with higher ketamine doses and may require increased positive end‑expiratory pressure or neuromuscular blockade. 3, 7
• Transient hypoxia occurs in 1.8% of patients (95% CI 0.1–3.6%) and typically resolves with ventilator adjustments. 7

Adjunctive Benzodiazepine Therapy

• Administer midazolam 2–5 mg IV bolus at the time of ketamine initiation to prevent emergence reactions (3.5% incidence, 95% CI 1.4–5.6%) and reduce the total ketamine dose required. 1, 7
• A combined ketamine–midazolam infusion can be prepared by mixing ketamine 200 mg + midazolam 5 mg in 50 mL saline, then infusing at a rate (mL/hour) equal to 50% of body weight in kg (50 mL/hour for a 100‑kg patient), delivering ketamine 200 mg/hour (2 mg/kg/hour) and midazolam 5 mg/hour. 4
• This higher‑dose combined regimen is appropriate for general anesthesia but should not be used for sedation in a hypotensive patient, as it exceeds safe ketamine infusion rates and increases the risk of cardiovascular collapse. 3, 4

Common Pitfalls to Avoid

• Never administer ketamine as a rapid IV bolus in a hypotensive patient, as this markedly increases the risk of respiratory depression and exaggerated vasopressor response. 1
• Do not use ketamine doses >2 mg/kg (200 mg total for a 100‑kg patient) as an induction bolus in hypotensive patients, as this is associated with a sevenfold increase in hypotension risk. 3
• Avoid mixing ketamine with sodium bicarbonate or other alkaline solutions in the same IV line, as alkalinity inactivates catecholamines if vasopressors are co‑administered. 5
• Do not rely on ketamine alone to maintain blood pressure; its sympathomimetic effects are unreliable in critically ill patients with depleted endogenous catecholamine stores, and 30.5% of agitated patients receiving ketamine require intubation (95% CI 27.0–34.1%), often due to hemodynamic instability. 7

Duration and Weaning

• Maintain the ketamine infusion at the minimum effective rate (typically 10–20 mL/hour or 0.1–0.2 mg/kg/hour) for the duration of agitation or until the underlying cause is addressed. 1
• When weaning, reduce the infusion rate by 25–50% every 30–60 minutes while monitoring for re‑emergence of agitation. 6
• Abrupt discontinuation is not necessary, as ketamine has a short context‑sensitive half‑time and emergence typically occurs within 10–20 minutes after stopping the infusion. 1